NURS 6630 MIDTERM EXAM STUDY GUIDE
Non-compliant patients
Neurotransmitters
Gene Expression
Cytochrome P450 Enzyme System
Pharmacokinetics
Mechanisms of receptors including:
o G-Protein linked receptors
o nicotine cholinergic
o serotonin
o dopamine
o norepinephrine
o D2 receptors
o glycine receptors
o ionotropic receptors
Medications classifications – Full agonists, antagonists, partial agonist, and inverse agonists
Therapeutics, side effects, dosing, use, and special populations for medications to treat
o Psychosis and schizophrenia
o bipolar disorders
o depression
o mania
o paranoid psychosis
o panic disorders
o fibromyalgia
o smoking cessation
o Parkinson’s disease
o anxiety
o stress
o PTSD
How to identify improvement in a patient following administration of medication
System-based approaches to treatment
MAO inhibitors
Stahl’s Essential Psychopharmacology
Chapter 1 – Chemical Neurotransmission
Anatomical versus chemical basis of neurotransmission
Non-compliant patients
Neurotransmitters
Gene Expression
Cytochrome P450 Enzyme System
Pharmacokinetics
Mechanisms of receptors including:
o G-Protein linked receptors
o nicotine cholinergic
o serotonin
o dopamine
o norepinephrine
o D2 receptors
o glycine receptors
o ionotropic receptors
Medications classifications – Full agonists, antagonists, partial agonist, and inverse agonists
Therapeutics, side effects, dosing, use, and special populations for medications to treat
o Psychosis and schizophrenia
o bipolar disorders
o depression
o mania
o paranoid psychosis
o panic disorders
o fibromyalgia
o smoking cessation
o Parkinson’s disease
o anxiety
o stress
o PTSD
How to identify improvement in a patient following administration of medication
System-based approaches to treatment
MAO inhibitors
Stahl’s Essential Psychopharmacology
Chapter 1 – Chemical Neurotransmission
Anatomical versus chemical basis of neurotransmission
